Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Clin Periodontol ; 41(3): 295-302, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24433307

RESUMEN

AIM: We hypothesized that platelet inactivation induced by drugs might interfere with periodontal repair in experimental periodontitis by suppressing the release of biological mediators from platelets at the site of injury. MATERIAL AND METHODS: Sixty rats were randomly assigned to six groups (n = 10) and ligatures were placed around lower first molars of three groups. The other three groups were used as negative controls. Ligatures were removed after 10 days of periodontitis induction and all groups were submitted to treatment with aspirin (Asp) (30 mg/kg), clopidogrel (Clop) (75 mg/kg) or NaCl 0.9% intra-gastrically once daily for 3 days. Periodontal tissue was assessed by the measurement of CXCL12, CXCL4, CCL5 and platelet-derived growth factor (PDGF) by enzyme-linked immunosorbent assay; histomorphometrical analysis of polymorphonuclear (PMN) infiltration, attachment loss, bone loss and osteoclast numbers and quantification of blood vessels by imunnohistochemistry. RESULTS: During periodontal repair and treatment with NaCl 0.9%, CCL5 was decreased and CXCL12 increased when compared with negative control groups. Asp and Clop did not affect CCL5 expression, decreased CXCL12 but only Clop decreased CXCL4 and PDGF content compared with saline-treated animals. Clop increased blood vessel number, reduced PMN count and decreased attachment and bone loss, also decreased osteoclast number in animals submitted or not to periodontal repair. CONCLUSION: Systemic administration of Clop for 3 days improved the repair process associated with experimental periodontal disease, suggesting that it may have therapeutic value under situations where tissues undergo a transition from inflammation to repair.


Asunto(s)
Periodontitis/tratamiento farmacológico , Periodoncio/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Ticlopidina/análogos & derivados , Pérdida de Hueso Alveolar/tratamiento farmacológico , Animales , Aspirina/administración & dosificación , Aspirina/uso terapéutico , Recuento de Células , Quimiocina CCL5/efectos de los fármacos , Quimiocina CXCL12/efectos de los fármacos , Clopidogrel , Infusiones Parenterales , Masculino , Microvasos/efectos de los fármacos , Infiltración Neutrófila/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Pérdida de la Inserción Periodontal/tratamiento farmacológico , Inhibidores de Agregación Plaquetaria/administración & dosificación , Factor Plaquetario 4/efectos de los fármacos , Factor de Crecimiento Derivado de Plaquetas/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Cloruro de Sodio , Ticlopidina/administración & dosificación , Ticlopidina/uso terapéutico
2.
J Endod ; 40(1): 95-100, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24331998

RESUMEN

INTRODUCTION: Production of chemokines by tissue resident cells is one of the main mechanisms involved in the inflammatory infiltrate formation during inflammation. The specific ability of fibroblasts from different oral tissues such as gingiva, periodontal ligament, and dental pulp from permanent and deciduous teeth in producing the chemokines CCL3 and CXCL12 under stimulation by bacterial products commonly found in endodontic infections was investigated. METHODS: Cultures of fibroblasts from gingiva and periodontal ligament as well as from dental pulp from permanent and deciduous teeth were established by using an explant technique and stimulated with increasing concentrations of Escherichia coli lipopolysaccharide (EcLPS) and Enterococcus faecalis lipoteichoic acid (EfLTA) for 1, 6, and 24 hours. Supernatants were tested for CCL3 and CXCL12 by enzyme-linked immunosorbent assay. RESULTS: In general, CCL3 production was induced by EcLPS in the 4 fibroblast subtypes and by EfLTA in fibroblasts from gingiva and periodontal ligament. Constitutive CXCL12 synthesis decreased in all fibroblast subtypes especially under stimulation with EcLPS. Fibroblast from permanent deciduous teeth was the cell type presenting the most expressive reduction in CXCL12 release by both stimuli. On the basis of computational matching of CXCL12 mRNA with the microRNAs miR-141 and miR-200a, their expression was also investigated. Although detected in the fibroblasts, these molecules remained unaltered by bacterial by-product stimulation. CONCLUSIONS: EcLPS and EfLTA induced the production of CCL3 and unbalanced the synthesis of CXCL12 in a manner dependent on the specific tissue origin of fibroblasts.


Asunto(s)
Quimiocina CCL3/efectos de los fármacos , Quimiocina CXCL12/efectos de los fármacos , Pulpa Dental/citología , Fibroblastos/efectos de los fármacos , Encía/citología , Lipopolisacáridos/farmacología , Ligamento Periodontal/citología , Ácidos Teicoicos/farmacología , Adolescente , Adulto , Técnicas de Cultivo de Célula , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Niño , Colorantes , Pulpa Dental/efectos de los fármacos , Enterococcus faecalis , Escherichia coli , Encía/efectos de los fármacos , Humanos , MicroARNs/análisis , Ligamento Periodontal/efectos de los fármacos , Fenotipo , Sales de Tetrazolio , Tiazoles , Diente Primario/citología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA